EFFICACY OF BIOACTIVE HERBAL PREPARATIONS IN PATIENTS WITH ULTRASOUND SIGNS OF BENIGN BREAST DYSPLASIA AND MASTALGIA
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Objective. To evaluate the clinical efficacy and safety of a herbal drug combination manufactured by Alfit Plus compony (Fitol-1 Mastoprof capsules + Mastokrel cream gel) as monotherapy in reproductive-aged patients with ultrasound signs of benign breast dysplasia and mastalgia. Materials and Methods. A single-center, open, prospective, pre-post comparative study was conducted. The study included 30 patients aged 21 to 45 years with mastalgia (VAS intensity >40 mm) and ultrasound signs of benign breast dysplasia corresponding to BIRADS category 2. Exclusion criteria were BIRADS ≥3, the use of hormonal medications, and severe somatic pathology. At baseline and after 3 months, the following parameters were evaluated: complaints, pain intensity using VAS, breast ultrasound data (on days 7–9 of the menstrual cycle), anthropometric measurements, blood pressure, and heart rate. Patients received Fitol-1 Mastoprof (1 capsule twice daily, per os) and Mastokrel cream gel (applied to the breasts morning and evening) for 3 months. Statistical analysis was performed using paired Student's t-test and χ² test (significance set at p
Fields of Study & Subjects
Breast Lesions and Carcinomas
Complementary and Alternative Medicine Studies
Traditional Chinese Medicine Clinical Research
Publication details
- Journal / source
- Bulletin of Medical Science
- Volume
- 38
- Issue
- 1
- Pages
- 52–57
- Publication date
- 1 January 2026
- Language
- EN